Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

China's primates: EU can't have it all ways

We are concerned about the prospect of China becoming a world leader in research involving non-human primates, given the country's comparatively weak regulatory system and ethical framework (see Nature 532, 281; 2016 and Nature 532, 300–302; 2016).

China's relative freedom from the “ethical pressure” you mention makes it attractive to researchers working on primates. But animal studies that could fail the harm–benefit evaluation in many Western regulatory systems should not be allowed — or actively encouraged — to take place elsewhere. Far from putting researchers under negative ethical pressure, the project-authorization process in the European Union was set up with full input from scientists and is often held up (by them) as an appropriate safeguard to promote good quality, ethically conducted science and good animal welfare (Nature 521, 7; 2015). You cannot have it both ways.

Rather than exploiting weaker animal-research regulations, we argue that more effort should be invested in developing and validating alternative technologies to avoid or reduce the use of non-human primates.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Penny Hawkins.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hawkins, P., Littlefair, P. China's primates: EU can't have it all ways. Nature 534, 179 (2016). https://doi.org/10.1038/534179b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/534179b

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing